Pulmonary hypertension

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 28, Issue 10, 2006, Pages 720-731

  Fleming, Emilie ^a,b   Ettinger, Stephen J ^a  

^a California Animal Hospital   (United States)

^b Animal Specialty Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751015719     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Rich S: Pulmonary hypertension, in Braunwald E (ed): Heart Disease: A Text book of Cardiovascular Medicine, ed 5. Philadelphia, WB Saunders, 1997, pp 1908-1931.
2. Farber HW, Loscalzo J: Mechanism of disease pulmonary arterial hypertension. N Engl J Med 351(16):1655-1663, 2004.
3. Johnson LR, Boon J, Orton EC: Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension. J Vet Intern Med 13:440-447, 1999.
4. Johnson LR: Diagnosis of pulmonary hypertension. Clin Tech Small Anim Pract 14(2):231-236, 1999.
5. Ettinger SJ, Suter PF: Cardiac catheterization and angiocardiography. Canine Cardiology. Philadelphia, WB Saunders, 1971.
6. Kienle KD, Kittleson MD: Pulmonary arterial and systemic arterial hypertension, in Kittleson MD (ed): Small Animal Cardiovascular Medicine, St. Louis, Mosby, 1998, pp 433-438.
7. West JB: Respiratory Physiology: The Essentials, ed 5. Baltimore, Williams & Wilkins, 1995.
8. Pyle RL, Abbot J, MacLean H: Severe pulmonary hypertension and cardiovascular sequelae in dogs. Vet Med 99(6):530-541, 2004.
9. Presberg KW, Dincer HE: Pathophysiology of pulmonary hypertension due to lung disease. Curr Opin Pulm Med 9(2):131-138, 2003.
10. Oswald GP, Orton EC: Patent ductus arteriosus and pulmonary hypertension in related Pembroke Welsh corgis. JAVMA 202(5):761-764, 1993.
11. Glaus TM, Hassig M, Baumgartner C, et al: Pulmonary hypertension induced in dogs by hypoxia at different high-altitude levels. Vet Res Commun 27:661-670, 2003.
12. Glaus TM, Hauser K, Hassig M, et al: Non-invasive measurement of the cardiovascular effects of chronic hypoxaemia on dogs living at moderately high altitude. Vet Record 152(26):800-803, 2003.
13. Johnson LR, Hamlin RL: Recognition and treatment of pulmonary hypertension, in Bonagura JD (ed): Kirk's Current Veterinary Therapy XII: Small Animal Practice. Philadelphia, WB Saunders, 1995, pp 887-892.
14. Lobetti RG, Milner R, Lane E: Chronic idiopathic pulmonary fibrosis in five dogs. JAAHA 37:119-127, 2001.
15. Gladwin MT, Sachdev V, Jison ML, et al: Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350(9):886-895, 2004.
16. Tilley LP: Essentials of Canine and Feline Electrocardiography, ed 3. Philadelphia, Lea & Febiger, 1992.
17. Boone J: Manual of Veterinary Echocardiography. Philadelphia, Lippincott Williams & Wilkins, 1998.
18. Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med 351(14):1425-1436, 2004.
19. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 336(2):111-117, 1997.
20. Broberg C, Gatzoulis M: Recent advances in the treatment of pulmonary hypertension. Hellenic J Cardiol 46:165-173, 2005.
21. Maloney JP: Advances in the treatment of secondary pulmonary hypertension. Curr Opin Pulm Med 9(2):139-143, 2003.
22. Michelakis ED, Tymchak W, Noga M, et al: Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108(17): 2066-2069, 2003.
23. Humpl T, Reyes JT, Holtby H, et al: Beneficial effect of oral sildenafil therapy on childhood pulmonary hypertension: Twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 111(24):3274-3280, 2005.
24. Wharton J, Strange JW, Moller GM, et al: Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery crlls. Am J Respir Crit Care Med 172(1):105-113, 2005.